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CASE REPORT:
FIBROLAMELLAR CARCINOMA OF THE LIVER--
A CASE REPORT FROM JAPAN AND A REVIEW OF
THE LITERATURE
HITOSHI KOHNO, NAOFUMI NAGASUE*, HIROYUKI TANIURA,
TERUHISA NAKAMURA and SABRO NAGAOKA
Second Department of Surgery and Clinical Department of Pathology, Shimane
Medical University, Izumo 693, Japan
The first Japanese case of fibrolamellar carcinoma (FLC) of the liver is described. The 17-year-old
Japanese male affected died of the disease 25 months after palliative operation. The diagnosis ofFLC had
not been confirmed before autopsy. Pre-operative diagnosis ofFLC is important to surgeons. Acccording
to the literature, FLC is rare in Asia. The endemic discrepancy may suggest that the carcinogenic factors
are different from those of general hepatocellular carcinoma.
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INTRODUCTION
Fibrolamellar carcinoma (FLC) of the liver has been widely recognized as a subtype
of hepatocellular carcinoma (HCC) since 19801’2. We herein report on a Japanese
teenager affected by FLC.
CASE REPORT
A 17-year-old Japanese male underwent a laparotomy under pre-operative diagnosis
of choledocholithiasis at Shimane Medical University on 27 December 1980. The
choledochotomy revealed yellow-greenish emboli in the bile ducts. The histologies
of both the emboli and the biopsied lymphnodes indicated HCCs (Figure 1). But it
was not suggested that this HCC was FLC at that moment. Serum level of alpha-
fetoprotein was below 5 ng/ml and that of carcino-embryonic antigen below 2.5 ng/
ml. The patient was negative for both hepatitis B surface antigen and antibody. The
second laparotomy revealed the hepatoma (8 x 8 x 8 cm) at the right hepatic lobe.
Although hepatic-arteries ligation and infusion chemotherapy (5.25 g of 5-
fluorouracil and 100 mg of Doxorubicin) were performed, the patient died on 9
February 1983. It was realized at the postmortem examination that the HCC of this
patient was a special subtype.
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Figure Histology of the tumor in the common hepatic duct shows lamellar fibrosis and polygonal
malignant hepatocytes (H & E 25).
DISCUSSION
In this case, the diagnosis of FLC was not made before autopsy. Although FLC has
some diagnostic characteristics-, it seems difficult to make a definitive diagnosis
before surgery in most patients6. Even so, such diagnosis may be necessary for
surgeons to perform aggressive hepatic resection, since FLC can promise a relatively
favorable prognosis after resection. This point has been stressed recently by
Dawson7. Furthermore, Calne
8 and Starzl et al.
9 have claimed that FLC is also a
better candidate for liver transplantation.
Incidentally, the patient also had tumor invasion of bile ducts. It is worthwhile to
note that FLC, like general HCC, develops intraductal tumor growth in some
patientsa.
As far as we know from the literature, there have been 143 cases of FLC (Table
1)1-6’9-32. In Asia, whereHCC is more frequent than in the West, there are only three
cases, including the present case. The carcinogenic factors ofFLC might be different
from those of generalHCC. Perhaps a world-wide survey is necessary to clarify this.
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Table Endemic aspects of fibrolamellar carcinoma in the literaturea.
Area References Race ofpatient
White Black Yellow Unknown
North 1,2,4,6,9b,10, 4--22,
America 23b,24--28
Europe 3,5,11,29,30
Asia 13
61 6 53
19
2
Three patients reported by Jagirdar et a112, three by Stromeyer et al. 31 and nine by Goodman and Ishak
32
are omitted to avoid overlap of patients.
Overlap of patients between these two articles is avoided by careful comparison.
Our patient
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